Live
- Zero voter turnout in 6 Nagaland dists
- PM takes ‘atta’ dig at Pakistan
- Cong outdated: Rajnath
- Anantapur: Give no more chances to Jagan says Chandrababu Naidu
- Congress strategy to outwit BJP in North Telangana
- Festival of Demiocracy: 62% turnout in phase 1
- MyVoice: Views of our readers 20th April 2024
- Is US Prez weighing climate emergency declaration soon
- ‘AP people’ve made up their mind on double engine govt’
- Kakinada: Overwhelmed by Godavari love said CM YS Jagan Mohan Reddy
Malaria vaccine gets EU nod
The world\'s first malaria vaccine got a green light on Friday from European drugs regulators who recommended it should be licensed for use in babies in Africa at risk of the mosquito-borne disease. The shot, called RTS,S or Mosquirix and developed by British drugmaker GlaxoSmithKline in partnership with the PATH MalariaVaccine Initiative,
London: The world's first malaria vaccine got a green light on Friday from European drugs regulators who recommended it should be licensed for use in babies in Africa at risk of the mosquito-borne disease. The shot, called RTS,S or Mosquirix and developed by British drugmaker GlaxoSmithKline in partnership with the PATH MalariaVaccine Initiative, would be the first licensed human vaccine against aparasitic disease and could help prevent millions of cases of malaria in countries that use it.
Recommendations for a drug licence made by the European Medicines Agency (EMA) are normally endorsed by the European Commission within a couple of months. Mosquirix, also part-funded by the Bill & Melinda Gates Foundation, will also now be assessed by the World Health Organisation.
